BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21506752)

  • 1. NT5E mutations and arterial calcifications.
    Hofbauer LC; Hamann C; Schoppet M
    N Engl J Med; 2011 Apr; 364(16):1578; author reply 1579-80. PubMed ID: 21506752
    [No Abstract]   [Full Text] [Related]  

  • 2. NT5E mutations and arterial calcifications.
    Zylka MJ; Sowa NA
    N Engl J Med; 2011 Apr; 364(16):1579; author reply 1579-80. PubMed ID: 21506750
    [No Abstract]   [Full Text] [Related]  

  • 3. NT5E mutations and arterial calcifications.
    Schrader J
    N Engl J Med; 2011 Apr; 364(16):1578-9; author reply 1579-80. PubMed ID: 21506751
    [No Abstract]   [Full Text] [Related]  

  • 4. NT5E mutations and arterial calcifications.
    Riksen NP; Rongen GA
    N Engl J Med; 2011 Apr; 364(16):1579; author reply 1579-80. PubMed ID: 21506749
    [No Abstract]   [Full Text] [Related]  

  • 5. NT5E mutations and arterial calcifications.
    Eltzschig HK; Robson SC
    N Engl J Med; 2011 Apr; 364(16):1577-8; author reply 1579-80. PubMed ID: 21506753
    [No Abstract]   [Full Text] [Related]  

  • 6. NT5E mutations and arterial calcifications.
    St Hilaire C; Ziegler SG; Markello TC; Brusco A; Groden C; Gill F; Carlson-Donohoe H; Lederman RJ; Chen MY; Yang D; Siegenthaler MP; Arduino C; Mancini C; Freudenthal B; Stanescu HC; Zdebik AA; Chaganti RK; Nussbaum RL; Kleta R; Gahl WA; Boehm M
    N Engl J Med; 2011 Feb; 364(5):432-42. PubMed ID: 21288095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticum.
    Markello TC; Pak LK; St Hilaire C; Dorward H; Ziegler SG; Chen MY; Chaganti K; Nussbaum RL; Boehm M; Gahl WA
    Mol Genet Metab; 2011 May; 103(1):44-50. PubMed ID: 21371928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcification of joints and arteries with novel NT5E mutations with involvement of upper extremity arteries.
    Yoshioka K; Kuroda S; Takahashi K; Sasano T; Furukawa T; Matsumura A
    Vasc Med; 2017 Dec; 22(6):541-543. PubMed ID: 28825389
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73).
    Minor M; Alcedo KP; Battaglia RA; Snider NT
    Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1079-C1092. PubMed ID: 31461341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to the article of C. Markello et al. entitled "Vascular pathology of medial arterial calcifications in NT5E deficiency: Implications for the role of adenosine in pseudoxanthoma elasticum".
    Lefthériotis G; Vanakker O; Le Saux O; Martin L
    Mol Genet Metab; 2011 Jun; 103(2):199-200. PubMed ID: 21497121
    [No Abstract]   [Full Text] [Related]  

  • 11. Juxta-articular joint-capsule mineralization in CD73 deficient mice: similarities to patients with NT5E mutations.
    Li Q; Price TP; Sundberg JP; Uitto J
    Cell Cycle; 2014; 13(16):2609-15. PubMed ID: 25486201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial Calcification Due to Deficiency of CD73 (ACDC) As One of Rheumatic Diseases Associated With Periarticular Calcification.
    Ichikawa N; Taniguchi A; Kaneko H; Kawamoto M; Sekita C; Nakajima A; Yamanaka H
    J Clin Rheumatol; 2015 Jun; 21(4):216-20. PubMed ID: 26010187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated arterial calcifications of the lower extremities: A clue for NT5E mutation.
    de Nijs T; Albuisson J; Ockeloen CW; Legrand A; Jeunemaitre X; Schultze Kool LJ; Riksen NP
    Int J Cardiol; 2016 Jun; 212():248-50. PubMed ID: 27045881
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetics in arterial calcification: lessons learned from rare diseases.
    Nitschke Y; Rutsch F
    Trends Cardiovasc Med; 2012 Aug; 22(6):145-9. PubMed ID: 23122642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifocal calcific periarthritis with distinctive clinical and radiological features in patients with CD73 deficiency.
    Cudrici CD; Newman KA; Ferrante EA; Huffstutler R; Carney K; Betancourt B; Miettinen M; Siegel R; Katz JD; Nesti LJ; St Hilaire C; Lakshmipathy D; Wen H; Bagheri MH; Boehm M; Brofferio A
    Rheumatology (Oxford); 2021 Dec; 61(1):163-173. PubMed ID: 33744914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene symbol: NT5C3. Disease: pyrimidine 5'-nucleotidase (P5'N) deficiency.
    Manco L; Ribeiro ML
    Hum Genet; 2006 Jul; 119(6):673-4. PubMed ID: 17128459
    [No Abstract]   [Full Text] [Related]  

  • 17. Pyrimidine 5' nucleotidase deficiency.
    Rees DC; Duley JA; Marinaki AM
    Br J Haematol; 2003 Feb; 120(3):375-83. PubMed ID: 12580951
    [No Abstract]   [Full Text] [Related]  

  • 18. The genetic basis of the interaction between pyrimidine 5' nucleotidase I deficiency and hemoglobin E.
    Escuredo E; Marinaki AM; Duley JA; Thein SL; Rees DC
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1261-3. PubMed ID: 15571242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in exon 6 of the human NT5E gene is associated with aortic valve calcification.
    Kochan Z; Karbowska J; Gogga P; Kutryb-Zajac B; Slominska EM; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):726-731. PubMed ID: 27906615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of five Portuguese patients with pyrimidine 5'-nucleotidase deficient hemolytic anemia showing three new P5'N-I mutations.
    Manco L; Relvas L; Silva Pinto C; Pereira J; Almeida AB; Ribeiro ML
    Haematologica; 2006 Feb; 91(2):266-7. PubMed ID: 16461318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.